DnB Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-32,063	Closed	-$5.89M	–	660
2021 Q2	$5.89M	Sell	32,063 -956,820	-97%	-$164M	0.04%	336
2021 Q1	$151M	Buy	988,883 +701,261	+244%	+$108M	1.1%	17
2020 Q4	$44.9M	Buy	287,622 +187,158	+186%	+$24.1M	0.39%	43
2020 Q3	$11.5M	Sell	100,464 -647,872	-87%	-$69.9M	0.12%	132
2020 Q2	$84M	Sell	748,336 -27,570	-4%	-$2.93M	0.99%	19
2020 Q1	$69.7M	Buy	775,906 +739,747	+2,046%	+$72.6M	1.02%	18
2019 Q4	$3.91M	Sell	36,159 -11,326	-24%	-$1.21M	0.04%	289
2019 Q3	$4.65M	Buy	47,485 +2,216	+5%	+$250K	0.05%	252
2019 Q2	$5.93M	Buy	45,269 +11,362	+34%	+$1.46M	0.07%	206
2019 Q1	$4.58M	Buy	33,907 +8,011	+31%	+$996K	0.05%	232
2018 Q4	$2.52M	Sell	25,896 -1,279	-5%	-$151K	0.03%	325
2018 Q3	$3.78M	Buy	27,175 +967	+4%	+$121K	0.04%	275
2018 Q2	$3.25M	Buy	26,208 +1,100	+4%	+$129K	0.04%	285
2018 Q1	$2.8M	Buy	25,108 +2,300	+10%	+$275K	0.03%	305
2017 Q4	$2.73M	Hold	22,808	–	–	0.03%	308
2017 Q3	$3.2M	Hold	22,808	–	–	0.04%	262
2017 Q2	$2.78M	Sell	22,808 -600	-3%	-$69.8K	0.04%	274
2017 Q1	$2.84M	Buy	23,408 +2,100	+10%	+$271K	0.04%	268
2016 Q4	$2.61M	Sell	21,308 -8,600	-29%	-$1.05M	0.05%	243
2016 Q3	$3.66M	Buy	29,908 +10,100	+51%	+$1.3M	0.07%	196
2016 Q2	$2.31M	Buy	19,808 +800	+4%	+$114K	0.05%	243
2016 Q1	$2.65M	Buy	19,008 +7,700	+68%	+$1.13M	0.06%	229
2015 Q4	$2.16M	Sell	11,308 -200	-2%	-$34.9K	0.05%	226
2015 Q3	$1.8M	Buy	11,508 +700	+6%	+$128K	0.04%	229
2015 Q2	$1.95M	Hold	10,808	–	–	0.04%	234
2015 Q1	$1.87M	Sell	10,808 -300	-3%	-$54.3K	0.04%	244
2014 Q4	$2.06M	Buy	11,108 +1,100	+11%	+$204K	0.05%	223
2014 Q3	$1.66M	Buy	+10,008	New	+$1.64M	0.04%	238

Other funds holding ALXN